Health – Minister of Foreign Affairs and Foreign Affairs Morocco organized Science Day in Rabat on Wednesday with two scientists sharing technology on Parkinson 's disease. Dr Abdelhamid Morazzo experts Benazzouz and Rabia Bouali-Benazzouz, both residing in France, contributed to the scientific study of the disease in both countries.
The Tour Hassan hotel invited several experts from France and Morocco throughout the day to present scientific research and enrich debate on knowledge in the area of neurodegenerative diseases, especially Parkinson's disease.
This study day was aimed at fostering partnerships between the two shores of the Mediterranean, supporting projects that support Morocco's scientific research expertise, and facilitating the transfer of know-how through the platform. & # 39; high-tech equipment.
Thus, motor and non-motor symptoms of Parkinson's disease, including ethical aspects, medical and surgical treatment were included in the menu of this conference scheduled as part of the 13th District Implementation of CGEM. Dedicated to the Moroccan entrepreneurs of the world.
Advances in neuroscience research have greatly influenced understanding of the pathophysiology of neurological diseases and have enabled the development of therapies for specific pathologies. Abdelhamid Benazzouz and his collaborator on Parkinson's disease, the second neurodegenerative disease of Alzheimer's disease, account for 1% of the population after age 60, is the first person to develop a new neurosurgical treatment approach to male disease. Monkeys in the CNRS research department at Bordeaux University
Due to the success of this technology for animals, Dr. Benazzouz has been able to contribute to the relocation of Parkinson to French patients and recent Moroccan patients.
During the day, we focused on current international research on other neurodegenerative diseases.